Christopher P. Stanley

Mansfield Road
Oxford, ENG OX13QT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Human coronary microvascular contractile dysfunction associates with viable synthetic smooth muscle cells.

Human coronary microvascular contractile dysfunction associates with viable synthetic smooth muscle cells.

Journal: Cardiovascular research

Published: January 25, 2021

Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.

Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.

Journal: European heart journal

Published: August 02, 2018

Isolated Human Pulmonary Artery Structure and Function Pre- and Post-Cardiopulmonary Bypass Surgery.

Isolated Human Pulmonary Artery Structure and Function Pre- and Post-Cardiopulmonary Bypass Surgery.

Journal: Journal of the American Heart Association

Published: February 25, 2016

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

Journal: Pharmacological research

Published: February 11, 2016

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.

Journal: Cardiovascular research

Published: September 04, 2014

Vascular targets for cannabinoids: animal and human studies.

Vascular targets for cannabinoids: animal and human studies.

Journal: British journal of pharmacology

Published: June 14, 2013

Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.

Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.

Journal: Pharmacological research

Published: May 21, 2013

Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes.

Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes.

Journal: European journal of pharmacology

Published: May 15, 2013

Evaluation of a novel non-destructive catch and release technology for harvesting autologous adult stem cells.

Evaluation of a novel non-destructive catch and release technology for harvesting autologous adult stem cells.

Journal: PloS one

Published: October 10, 2012

Is the cardiovascular system a therapeutic target for cannabidiol?

Is the cardiovascular system a therapeutic target for cannabidiol?

Journal: British journal of clinical pharmacology

Published: June 08, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026